Mayo Clinic leads research on 'encouraging' plasma treatment for COVID-19

As more people become infected with the coronavirus, one of the therapies the FDA is exploring is the use of convalescent blood plasma from people who have already recovered. The Mayo Clinic is leading the research on behalf of the FDA and, so far, the results are encouraging.